• Cancel
    Date：2017-06

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date：2016-11

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date：2016-11

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date：2016-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=203

    Coyote Bioscience, a leading molecular diagnosis company in China, announced today that it had completed Series B financing. The round was led by Northern Light Ventures, with participation from SAIF Asia and Legend Star.

  • Cancel
    Date：2016-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=200

    Righton Biology, a specialized molecular diagnostics company with test kits for leukemia, lymphoma, and solid tumors, today announced that it had completed its Series A financing.

  • Cancel
    Date：2016-01

    -

  • Cancel
    Date：2016-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=199

    Xingshulin, a leading mobile app focused on providing data and management tools to physicians across the country, announced today that it had completed Series C financing.

  • Cancel
    Date：2015-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=205

    ET Healthcare, an advanced in-vitro diagnostic technology company, announced today that it had completed a new round of financing, led by Qiming Venture Partners and Masion Capital with participation from the compan's existing shareholders Legend Capital

  • Cancel
    Date：2015-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=211

    Sino-Kor Plastics Surgery Hospital (NEEQ: 430335), China's largest clinic and hospital chain in plastic surgery listed on China's New Third Board, announced today that it had completed a secondary offering to finance expansion of new hospitals and clinics